Simon Wandel

8.6k total citations · 5 hit papers
37 papers, 4.2k citations indexed

About

Simon Wandel is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Statistics and Probability. According to data from OpenAlex, Simon Wandel has authored 37 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Statistics and Probability. Recurrent topics in Simon Wandel's work include Coronary Interventions and Diagnostics (9 papers), Statistical Methods in Clinical Trials (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Simon Wandel is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Statistical Methods in Clinical Trials (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Simon Wandel collaborates with scholars based in Switzerland, United States and United Kingdom. Simon Wandel's co-authors include Peter Jüni, Matthias Egger, Sven Trelle, Peter M. Villiger, Stephan Reichenbach, Pius Hildebrand, Beat Neuenschwander, Robert Colebunders, Mónika Müller and Suzanna Attia and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Simon Wandel

37 papers receiving 4.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

2011 827 citations Sven Trelle, Stephan Reichenbach et al. BMJ profile →
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

2010 524 citations Simon Wandel, Matthias Egger et al. profile →
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

2013 499 citations Paolo A. Ascierto, Dirk Schadendorf et al. The Lancet Oncology profile →
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

2008 453 citations Stephan Windecker, Patrick W. Serruys et al. The Lancet profile →
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

2010 396 citations Simon Wandel, Peter Jüni et al. BMJ profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Simon Wandel	1.6k	988	696	691	587	37	4.2k
Lei Shen	1.2k 0.8×	1.7k 1.7×	1.1k 1.6×	446 0.6×	148 0.3×	119	6.4k
Koji Oba	1.4k 0.9×	633 0.6×	930 1.3×	216 0.3×	193 0.3×	273	5.7k
Dion Morton	1.9k 1.2×	709 0.7×	1.1k 1.6×	1.7k 2.4×	266 0.5×	111	6.3k
Toshimitsu Hamasaki	1.0k 0.6×	857 0.9×	954 1.4×	134 0.2×	79 0.1×	203	5.1k
Katherine P. Liao	593 0.4×	464 0.5×	1.0k 1.5×	128 0.2×	1.8k 3.1×	164	5.2k
George Cotsonis	1.1k 0.7×	865 0.9×	925 1.3×	276 0.4×	173 0.3×	134	5.6k
Martina Zaninotto	709 0.4×	1.6k 1.6×	669 1.0×	108 0.2×	179 0.3×	255	4.8k
Peter Wahl	1.4k 0.9×	517 0.5×	660 0.9×	147 0.2×	329 0.6×	145	4.6k
Pieter Vermeersch	539 0.3×	693 0.7×	1.2k 1.7×	183 0.3×	439 0.7×	173	5.1k
Delphine Maucort‐Boulch	1.1k 0.7×	370 0.4×	543 0.8×	92 0.1×	219 0.4×	176	4.7k

Countries citing papers authored by Simon Wandel

Since Specialization

Citations

This map shows the geographic impact of Simon Wandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Wandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Wandel more than expected).

Fields of papers citing papers by Simon Wandel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Wandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Wandel. The network helps show where Simon Wandel may publish in the future.

Co-authorship network of co-authors of Simon Wandel

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Wandel. A scholar is included among the top collaborators of Simon Wandel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Wandel. Simon Wandel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Best, Nicky, et al.. (2024). Beyond the Classical Type I Error: Bayesian Metrics for Bayesian Designs Using Informative Priors. Statistics in Biopharmaceutical Research. 17(2). 183–196. 5 indexed citations

Bhatia, Harpreet, Simon Wandel, Peter Willeit, et al.. (2024). Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis. Circulation. 151(4). 312–321. 26 indexed citations

Baillie, Mark, et al.. (2022). Rethinking clinical study data: why we should respect analysis results as data. Scientific Data. 9(1). 686–686. 3 indexed citations

Siah, Kien Wei, Nicholas Kelley, Björn Holzhauer, et al.. (2021). Predicting drug approvals: The Novartis data science and artificial intelligence challenge. Patterns. 2(8). 100312–100312. 25 indexed citations

Röver, Christian, Simon Wandel, & Tim Friede. (2018). Model averaging for robust extrapolation in evidence synthesis. Statistics in Medicine. 38(4). 674–694. 23 indexed citations

Bangalore, Sripal, Robert J. Fakheri, Simon Wandel, et al.. (2017). Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials. BMJ. 356. j4–j4. 52 indexed citations

Friede, Tim, Christian Röver, Simon Wandel, & Beat Neuenschwander. (2016). Meta‐analysis of few small studies in orphan diseases. Research Synthesis Methods. 8(1). 79–91. 127 indexed citations

Friede, Tim, Christian Röver, Simon Wandel, & Beat Neuenschwander. (2016). Meta‐analysis of two studies in the presence of heterogeneity with applications in rare diseases. Biometrical Journal. 59(4). 658–671. 89 indexed citations

Ascierto, Paolo A., Dirk Schadendorf, Carola Berking, et al.. (2013). MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. The Lancet Oncology. 14(3). 249–256. 499 indexed citations breakdown →

10.

Trelle, Sven, Stephan Reichenbach, Simon Wandel, et al.. (2011). Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 342(jan11 1). c7086–c7086. 827 indexed citations breakdown →

11.

Cooper, Nicola J., Jaime Peters, Peter Jüni, et al.. (2011). How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation?. Value in Health. 14(2). 371–380. 55 indexed citations

12.

Jüni, Peter, Simon Wandel, Michael Billinger, et al.. (2010). Sirolimus versus paclitaxel coronary stents in clinical practice. Catheterization and Cardiovascular Interventions. 77(1). 5–12. 8 indexed citations

13.

Räber, Lorenz, Peter Jüni, Lukas M. Löffel, et al.. (2010). Impact of Stent Overlap on Angiographic and Long-Term Clinical Outcome in Patients Undergoing Drug-Eluting Stent Implantation. Journal of the American College of Cardiology. 55(12). 1178–1188. 124 indexed citations

14.

Eshtehardi, Parham, Stéphane Cook, Simon Wandel, et al.. (2010). Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study. EuroIntervention. 6(4). 467–474. 9 indexed citations

15.

Wandel, Simon, Peter Jüni, Britta Tendal, et al.. (2010). Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 341(sep16 2). c4675–c4675. 396 indexed citations breakdown →

16.

Tendal, Britta, Julian P. T. Higgins, Peter Jüni, et al.. (2009). Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study. BMJ. 339(aug13 2). b3128–b3128. 61 indexed citations

17.

Windecker, Stephan, Patrick W. Serruys, Simon Wandel, et al.. (2008). Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet. 372(9644). 1163–1173. 453 indexed citations breakdown →

18.

Billinger, Michael, Jaap J. Beutler, Andréa Remondino, et al.. (2008). Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. European Heart Journal. 29(6). 718–725. 56 indexed citations

19.

Togni, Mario, Jeannette Widmer, Michael Billinger, et al.. (2007). Impact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 50(12). 1123–1131. 60 indexed citations

20.

Jüni, Peter, Stephan Reichenbach, Sven Trelle, et al.. (2007). Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial. Arthritis & Rheumatism. 56(11). 3610–3619. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact